NantHealth (NH) IPO Prices at $14 Moves Up To $18+…Update-1
Update -1 NH closes at $18.59 up 32.79% on volume of 3.3M shares. High was $21 low was $16.11. Market cap is $2.1B. Focus of the Company is personalized healthcare utilizing a unique software platform (NantOS) applying molecular diagnostics and genomics on patient tissues and integrated with...
Biotech Rally Moving Toward April Highs: ASCO and M&A Provides Underlying Support…Update-1
Update June 1... After Close Biotech Holds...Uh oh CNBC is talking about biotech. IBB 281.18, XBI 58.18 This stealth rally has been going steady for two weeks but now CNBC and its "Fast Money" show are talking up biotech so is this a jinx? And saying "party over" when the rally just started??...
Biotech Rally Fades But Plenty of Big Movers: ASCO June 6
Biotech Rally Fades after Five Days: IBB down 0.49%, XBI down 1% Biotech stocks were weak at the onset and could not come back but the sector is still up about 7% over five days. Stocks were mixed on thursday and healthcare was weak with the XLV flat at $70.84. The big mover was Alnylam...
Healthcare Sector Is Looking A Tad Better: M&A Boosts Biotech…Update-1
Update-1 "Growthier" market move sparked by housing data-new home sales jump 16.6% A broad rally today surprised many traders. Technology was a leader up 2% followed by healthcare up 1.49%. US new single family home sales hit an 8 year high a sign of growing prospects for the economy. The green...
Nothing New To Report: Green Screen Day…Update-1
Update: M&A will come back-- Pfizer (PFE) buys Anacor (ANAC) for $5.2B. Now you see why inversions are not good for biotech stocks as PFE had to give up reverse merger and go for growth. Last three posts are still on the mark. The 4% move today in XBI is encouraging ; the 6% move in...